Qi-Shan Dai

机构：Second Affiliated Hospital of Guangzhou Medical University, Guangzhou First People's Hospital, South China University of Technology, Guangzhou Medical University

发表论文 56 篇 · 总被引 1433 次 · h-index 22

代表论文

• miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer (2015 · Clinical Cancer Research · 被引 153)
• MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1 (2013 · International Journal of Cancer · 被引 110)
• Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer (2013 · Medical Oncology · 被引 66)
• Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer (2015 · BMC Urology · 被引 58)
• Expression of SOCSs in human prostate cancer and their association in prognosis (2013 · Molecular and Cellular Biochemistry · 被引 46)
• Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer. (2015 · PubMed · 被引 43)